Global estimates of diabetes-related amputations incidence in 2010–2020: A systematic review and meta-analysis
Great work from our Valencia and Pamplona
Global estimates of diabetes-related amputations incidence in 2010–2020: A systematic review and meta-analysis
Global estimates of diabetes-related amputations incidence in 2010–2020: A systematic review and meta-analysis
Yasmin Ezzatvara, Antonio García-Hermoso
Aims/hypothesis: This study sought to provide up-to-date pooled global estimates of diabetes-related amputation incidence from 2010 to 2020.
Methods: Embase and Medline databases were searched for studies reporting the incidence rate (IR) of diabetes- related amputations from 2010 to 2020. IR estimates of diabetes-related amputations with associated 95% confidence interval (CI) per 100,000 individuals with diabetes were calculated.
Results: 23 studies were included, reporting 505,390 diabetes-related lower extremity amputations. IR of minor amputations was 139.97 (95% CI 88.18–222.16) per 100,000 individuals with diabetes, among patients with type 1 diabetes was 148.59 (95% CI 65.00–339.68) and in type 2 diabetes was 75.53 (95% CI 29.94–190.54). IR of major amputations was 94.82 (95% CI 56.62–158.80) per 100,000 individuals with diabetes, among patients with type 1 diabetes was 100.76 (95% CI 53.71–189.01) and among type 2 diabetes was 40.58 (95% CI 11.03–149.28). There were 83.84 annual amputations (95% CI 41.67–168.65) per 100,000 women with diabetes and 178.04 (95% CI 81.16–390.55) per 100,000 men.
Conclusions: Globally, annual incidence of diabetes-related amputations from 2010 to 2020 has shown to disproportionately affect men and individuals with type 1 diabetes mellitus, although its incidence is not uniform across countries.
Leave a Reply